These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. Porter EA; Weisblum B; Gellman SH J Am Chem Soc; 2002 Jun; 124(25):7324-30. PubMed ID: 12071741 [TBL] [Abstract][Full Text] [Related]
4. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction. Mills NL; Daugherty MD; Frankel AD; Guy RK J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504 [TBL] [Abstract][Full Text] [Related]
5. Maintaining biological activity by using triazoles as disulfide bond mimetics. Holland-Nell K; Meldal M Angew Chem Int Ed Engl; 2011 May; 50(22):5204-6. PubMed ID: 21472909 [No Abstract] [Full Text] [Related]
7. Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides. Azmi F; Skwarczynski M; Toth I Curr Med Chem; 2016; 23(41):4610-4624. PubMed ID: 27570165 [TBL] [Abstract][Full Text] [Related]
8. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity. Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. Raguse TL; Porter EA; Weisblum B; Gellman SH J Am Chem Soc; 2002 Oct; 124(43):12774-85. PubMed ID: 12392424 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine. Lee CW; Cao H; Ichiyama K; Rana TM Bioorg Med Chem Lett; 2005 Oct; 15(19):4243-6. PubMed ID: 16054360 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates. Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514 [TBL] [Abstract][Full Text] [Related]
16. Influence of the Length and Charge on the Activity of α-Helical Amphipathic Antimicrobial Peptides. Gagnon MC; Strandberg E; Grau-Campistany A; Wadhwani P; Reichert J; Bürck J; Rabanal F; Auger M; Paquin JF; Ulrich AS Biochemistry; 2017 Mar; 56(11):1680-1695. PubMed ID: 28282123 [TBL] [Abstract][Full Text] [Related]
17. Helical structure of dermaseptin B2 in a membrane-mimetic environment. Lequin O; Bruston F; Convert O; Chassaing G; Nicolas P Biochemistry; 2003 Sep; 42(34):10311-23. PubMed ID: 12939161 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials. Jin Y; Hammer J; Pate M; Zhang Y; Zhu F; Zmuda E; Blazyk J Antimicrob Agents Chemother; 2005 Dec; 49(12):4957-64. PubMed ID: 16304158 [TBL] [Abstract][Full Text] [Related]